OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
182
Results
Show all
Save search
Copy query
Show results for
Unknown
(172)
Proteomics
(9)
Transcriptomics
(1)
Organisms
Methylocystis sp.
(9)
Bothrops insularis
(9)
Bothrops jararaca
(9)
Bothrops jararacussu
(9)
Bothrops cotiara
(9)
Streptomyces coelicolor
(9)
Burkholderia ubonensis MSMB22
(9)
Pseudomonas aeruginosa PA103
(9)
Artibeus jamaicensis
(9)
Morchella importuna
(9)
Bothrops brazili
(9)
Bothrops leucurus
(9)
Bothrops moojeni
(9)
Sclerotinia sclerotiorum
(9)
Brassica napus
(9)
Bothrops neuwiedi
(9)
Bartonella quintana JK 31
(9)
Bombyx mori
(9)
Onchocerca volvulus
(9)
Klebsiella pneumoniae
(9)
Musca domestica
(9)
Brugia malayi
(9)
Schizosaccharomyces pombe
(9)
Oryza sativa
(9)
Cnidaria
(9)
Streptomyces coelicolor A3(2)
(9)
Sus scrofa
(9)
Human immunodeficiency virus 1
(9)
Oryza sativa Indica Group
(9)
Danio rerio
(1)
Repository
pride
(9)
biostudies-arrayexpress
(1)
Tissue
Fibroblast
(4)
Cell culture
(2)
Peripheral blood mononuclear cell
(1)
Blood serum
(1)
Heart
(1)
Brain
(1)
Primary cell
(1)
Blood
(1)
Disease
Congenital disorder of glycosylation
(3)
Congenital disorder of glycosylation Iq
(1)
Cardiovascular system disease
(1)
Technology Type
Mass Spectrometry
(9)
Bottom-up proteomics
(5)
Shotgun proteomics
(3)
Data-dependent acquisition
(1)
Top-down proteomics
(1)
Instrument Platform
Illumina HiSeq 3000
(1)
Publication Date
2026
(4)
2023
(3)
2021
(1)
2025
(1)
2024
(1)
Study type
Animal - High-throughput sequencing
(1)
Release Date
2021
(28)
2024
(24)
2023
(24)
2022
(18)
2020
(17)
2019
(11)
2025
(9)
2018
(8)
2017
(7)
2014
(6)
2016
(5)
2010
(4)
2026
(3)
2012
(2)
2011
(2)
2009
(2)
2015
(1)
2013
(1)
2004
(1)
Lab affiliation
Department of Laboratory Medicine and Pathology Mayo Clinic, Rochester, Minnesota 55905 United States
(5)
IPHC-LSMBO
(1)
Akhilesh Pandey, M.D., Ph.D. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, United States
(1)
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota
(1)
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, United States
(1)
Previous
page
1 / 19
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
19
Next
page
Sort
by:
Relevance
Page size
10
Increasing volatility of reconstructed Morava River warm-season flow, Czech Republic.
Not available
S-EPMC10739599
|
biostudies-literature
Cite
CDG Therapies: From Bench to Bedside.
Not available
S-EPMC5983582
|
biostudies-literature
Cite
Recognizable phenotypes in CDG.
Not available
S-EPMC5960425
|
biostudies-literature
Cite
Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDG.
Not available
S-EPMC12839988
|
biostudies-literature
Cite
A Review of Epigenetics of PTSD in Comorbid Psychiatric Conditions.
Not available
S-EPMC6410143
|
biostudies-literature
Cite
Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update.
Not available
S-EPMC8720509
|
biostudies-literature
Cite
Exome sequencing can misread high variant allele fraction of somatic variants in UBA1 as hemizygous in VEXAS syndrome: a case report.
Not available
S-EPMC9426024
|
biostudies-literature
Cite
Defining the phenotype of PGAP3-congenital disorder of glycosylation; a review of 65 cases.
Not available
S-EPMC10872732
|
biostudies-literature
Cite
Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG.
Not available
S-EPMC4180034
|
biostudies-literature
Cite
Liver transplantation recovers hepatic N-glycosylation with persistent IgG glycosylation abnormalities: Three-year follow-up in a patient with phosphomannomutase-2-congenital disorder of glycosylation.
Not available
S-EPMC10164344
|
biostudies-literature
Cite
Previous
page
1 / 19
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
19
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
